Novo Nordisk, European Medicines Agency and Ozempic

Novo Nordisk’s Ozempic Gets EU Regulator Endorsement to Reduce Kidney Risks
Novo Nordisk said the European Union’s drug regulator supports a label expansion of its Ozempic diabetes drug to reflect its potential to lower the risk of conditions related to kidney disease in adults with Type 2 diabetes.
Europe allows Novo to include reduction of kidney disease in Ozempic label
The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes drug Ozempic, the Danish drugmaker said in a statement on Thursday.
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and cardiovascular risk reduction.
Novo Nordisk's Ozempic Gets CHMP's Positive Opinion To Include Kidney Disease Label Update
Thursday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has supported label update for weight-loss drug Ozempic to include kidney disease risk reduction.
Novo Nordisk's Ozempic set to include kidney treatment label in EU
Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss drug Ozempic to include the reduction of kidney disease risk. The decision was based on findings of a trial,
The Ozempic Flip-Flop
A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...
Ozempic insights: What we’ve learned so far
We know that the popular weight-loss drug Ozempic can help people shed significant weight, but as the number of users ...
Elon Musk reveals support for drugs like Ozempic — in direct contrast to Trump’s HHS pick RFK Jr.
Elon Musk, one of President-elect Donald Trump’s closest confidants, revealed Wednesday his support for weight-loss drugs ...
Ozempic Killed Diet and Exercise
Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.
Ozempic and Other Weight Loss Drugs Could Shrink Medical Bills, Too
A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.
What is Mounjaro? The Ozempic-style weight-loss drug being rolled out on the NHS
They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
Weight loss costs: Iowans struggle with insurance and access to ozempic, other GLP-1 drugs
Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...
Ozempic Not Working for You? A Stomach Balloon Is the Latest Hope for Weight Loss
MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.
I lost half my body weight on Ozempic – this is what happened when I stopped
With her appetite suppressed on the weekly injections, by spring last year Ashley had lost 12 stone – nearly half her body ...